Giovanni Matera

Inhibition of toll‐like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis

Shahla Abdollahi‐Roodsaz, Leo A. B. Joosten, Mieke F. Roelofs et al. · Arthritis & Rheumatism · 2007 · 303 citations

Life Sciences, Immunology, Pathology +17

Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility

Enrico Maria Trecarichi, Maria Mazzitelli, Francesca Serapide et al. · Scientific Reports · 2020 · 93 citations · Full text

Veterinary Medicine, Geriatric Medicine, Infectious Diseases +13

<i>Bartonella quintana</i>Lipopolysaccharide Is a Natural Antagonist of Toll-Like Receptor 4

Călin D. Popa, Shahla Abdollahi‐Roodsaz, Leo A. B. Joosten et al. · Infection and Immunity · 2007 · 84 citations · Full text

Life Sciences, Immunology, Microbiology +17

Efficacy of cefiderocol- vs colistin-containing regimen for treatment of bacteraemic ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii in patients with COVID-19

Alessandro Russo, Andrea Bruni, Sara Palma Gullì et al. · International Journal of Antimicrobial Agents · 2023 · 79 citations · Full text

Pharmacy, Infectious Diseases, Pharmacokinetics +17

Changes in the prevalence of hepatitis C virus (HCV) genotype 4 in Calabria, Southern Italy

Giovanni Matera, Angelo Giuseppe Lamberti, Angela Quirino et al. · Diagnostic Microbiology and Infectious Disease · 2002 · 73 citations

Life Sciences, Infectious Diseases, Microbiology +11